219 related articles for article (PubMed ID: 31982140)
1. Targeting DUSP16/TAK1 signaling alleviates hepatic dyslipidemia and inflammation in high fat diet (HFD)-challenged mice through suppressing JNK MAPK.
Wu YK; Hu LF; Lou DS; Wang BC; Tan J
Biochem Biophys Res Commun; 2020 Mar; 524(1):142-149. PubMed ID: 31982140
[TBL] [Abstract][Full Text] [Related]
2. Dual-Specificity Phosphatase 26 Protects Against Nonalcoholic Fatty Liver Disease in Mice Through Transforming Growth Factor Beta-Activated Kinase 1 Suppression.
Ye P; Liu J; Xu W; Liu D; Ding X; Le S; Zhang H; Chen S; Chen M; Xia J
Hepatology; 2019 May; 69(5):1946-1964. PubMed ID: 30582764
[TBL] [Abstract][Full Text] [Related]
3. Hepatocyte DUSP14 maintains metabolic homeostasis and suppresses inflammation in the liver.
Wang S; Yan ZZ; Yang X; An S; Zhang K; Qi Y; Zheng J; Ji YX; Wang PX; Fang C; Zhu XY; Shen LJ; Yan FJ; Bao R; Tian S; She ZG; Tang YD
Hepatology; 2018 Apr; 67(4):1320-1338. PubMed ID: 29077210
[TBL] [Abstract][Full Text] [Related]
4. Targeting DUSP7 signaling alleviates hepatic steatosis, inflammation and oxidative stress in high fat diet (HFD)-fed mice via suppression of TAK1.
Wu L; Liu Y; Zhao Y; Li M; Guo L
Free Radic Biol Med; 2020 Jun; 153():140-158. PubMed ID: 32311490
[TBL] [Abstract][Full Text] [Related]
5. Liensinine alleviates high fat diet (HFD)-induced non-alcoholic fatty liver disease (NAFLD) through suppressing oxidative stress and inflammation via regulating TAK1/AMPK signaling.
Liang L; Ye S; Jiang R; Zhou X; Zhou J; Meng S
Int Immunopharmacol; 2022 Mar; 104():108306. PubMed ID: 34999396
[TBL] [Abstract][Full Text] [Related]
6. Tumor Necrosis Factor α-Induced Protein 8-Like 2 Alleviates Nonalcoholic Fatty Liver Disease Through Suppressing Transforming Growth Factor Beta-Activated Kinase 1 Activation.
Liu Y; Song J; Yang J; Zheng J; Yang L; Gao J; Tian S; Liu Z; Meng X; Wang JC; Dai Z; Tang YD
Hepatology; 2021 Sep; 74(3):1300-1318. PubMed ID: 33768585
[TBL] [Abstract][Full Text] [Related]
7. Hepatic Regulator of G Protein Signaling 5 Ameliorates Nonalcoholic Fatty Liver Disease by Suppressing Transforming Growth Factor Beta-Activated Kinase 1-c-Jun-N-Terminal Kinase/p38 Signaling.
Wang J; Ma J; Nie H; Zhang XJ; Zhang P; She ZG; Li H; Ji YX; Cai J
Hepatology; 2021 Jan; 73(1):104-125. PubMed ID: 32191345
[TBL] [Abstract][Full Text] [Related]
8. Expression of Vsig4 attenuates macrophage-mediated hepatic inflammation and fibrosis in high fat diet (HFD)-induced mice.
Li Y; Sun JP; Wang J; Lu WH; Xie LY; Lv J; Li HX; Yang SF
Biochem Biophys Res Commun; 2019 Aug; 516(3):858-865. PubMed ID: 31266632
[TBL] [Abstract][Full Text] [Related]
9. USP18 protects against hepatic steatosis and insulin resistance through its deubiquitinating activity.
An S; Zhao LP; Shen LJ; Wang S; Zhang K; Qi Y; Zheng J; Zhang XJ; Zhu XY; Bao R; Yang L; Lu YX; She ZG; Tang YD
Hepatology; 2017 Dec; 66(6):1866-1884. PubMed ID: 28718215
[TBL] [Abstract][Full Text] [Related]
10. Allyl isothiocyanate ameliorates lipid accumulation and inflammation in nonalcoholic fatty liver disease
Li CX; Gao JG; Wan XY; Chen Y; Xu CF; Feng ZM; Zeng H; Lin YM; Ma H; Xu P; Yu CH; Li YM
World J Gastroenterol; 2019 Sep; 25(34):5120-5133. PubMed ID: 31558861
[TBL] [Abstract][Full Text] [Related]
11. Hepatocyte TRAF3 promotes liver steatosis and systemic insulin resistance through targeting TAK1-dependent signalling.
Wang PX; Zhang XJ; Luo P; Jiang X; Zhang P; Guo J; Zhao GN; Zhu X; Zhang Y; Yang S; Li H
Nat Commun; 2016 Feb; 7():10592. PubMed ID: 26882989
[TBL] [Abstract][Full Text] [Related]
12. Tumor Progression Locus 2 in Hepatocytes Potentiates Both Liver and Systemic Metabolic Disorders in Mice.
Gong J; Fang C; Zhang P; Wang PX; Qiu Y; Shen LJ; Zhang L; Zhu XY; Tian S; Li F; Wang Z; Huang Z; Wang A; Zhang XD; She ZG
Hepatology; 2019 Feb; 69(2):524-544. PubMed ID: 29381809
[TBL] [Abstract][Full Text] [Related]
13. Functional involvement of dual specificity phosphatase 16 (DUSP16), a c-Jun N-terminal kinase-specific phosphatase, in the regulation of T helper cell differentiation.
Musikacharoen T; Bandow K; Kakimoto K; Kusuyama J; Onishi T; Yoshikai Y; Matsuguchi T
J Biol Chem; 2011 Jul; 286(28):24896-905. PubMed ID: 21613215
[TBL] [Abstract][Full Text] [Related]
14. Targeting hepatic TRAF1-ASK1 signaling to improve inflammation, insulin resistance, and hepatic steatosis.
Xiang M; Wang PX; Wang AB; Zhang XJ; Zhang Y; Zhang P; Mei FH; Chen MH; Li H
J Hepatol; 2016 Jun; 64(6):1365-77. PubMed ID: 26860405
[TBL] [Abstract][Full Text] [Related]
15. DUSP16 is an epigenetically regulated determinant of JNK signalling in Burkitt's lymphoma.
Lee S; Syed N; Taylor J; Smith P; Griffin B; Baens M; Bai M; Bourantas K; Stebbing J; Naresh K; Nelson M; Tuthill M; Bower M; Hatzimichael E; Crook T
Br J Cancer; 2010 Jul; 103(2):265-74. PubMed ID: 20551953
[TBL] [Abstract][Full Text] [Related]
16. GCSF deficiency attenuates nonalcoholic fatty liver disease through regulating GCSFR-SOCS3-JAK-STAT3 pathway and immune cells infiltration.
Zhang Y; Zhou X; Liu P; Chen X; Zhang J; Zhang H; Li S; Chen Y; Song X; Wang J; Zeng H; Zhang X; Tang C; Yu C; Li Y; Xu C
Am J Physiol Gastrointest Liver Physiol; 2021 Apr; 320(4):G531-G542. PubMed ID: 33470903
[TBL] [Abstract][Full Text] [Related]
17. Exercise ameliorates insulin resistance via regulating TGFβ-activated kinase 1 (TAK1)-mediated insulin signaling in liver of high-fat diet-induced obese rats.
Zhang Y; Wan J; Xu Z; Hua T; Sun Q
J Cell Physiol; 2019 May; 234(5):7467-7474. PubMed ID: 30367484
[TBL] [Abstract][Full Text] [Related]
18. C-Jun/C7ORF41/NF-κB axis mediates hepatic inflammation and lipid accumulation in NAFLD.
Yan FJ; Wang X; Wang SE; Hong HT; Lu J; Ye Q; Zheng YL; Wang YJ
Biochem J; 2020 Feb; 477(3):691-708. PubMed ID: 31957809
[TBL] [Abstract][Full Text] [Related]
19. Ubiquitin-Specific Protease 4 Is an Endogenous Negative Regulator of Metabolic Dysfunctions in Nonalcoholic Fatty Liver Disease in Mice.
Zhao Y; Wang F; Gao L; Xu L; Tong R; Lin N; Su Y; Yan Y; Gao Y; He J; Kong L; Yuan A; Zhuge Y; Pu J
Hepatology; 2018 Sep; 68(3):897-917. PubMed ID: 29573006
[TBL] [Abstract][Full Text] [Related]
20. MKP-5 Relieves Lipotoxicity-Induced Islet β-Cell Dysfunction and Apoptosis via Regulation of Autophagy.
Zhao T; Ma J; Li L; Teng W; Tian Y; Ma Y; Wang W; Yan W; Jiao P
Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32998359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
